Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 10, 1997, Pages 1142-1146

  Rushing, Elisabeth J ^a   Yashima, Kazuo ^b   Brown, Daniel F ^a   White III, Charles L ^a   Shay, Jerry W ^a   Risser, Richard C ^b   Gazdar, Adi F ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ependymoma; MIB 1; Proliferation index; Telomerase

Indexed keywords

MONOCLONAL ANTIBODY KI 67; RNA; TELOMERASE;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0030954725     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199710000-00008     Document Type: Article

References (31)

1. Morin GB. Is telomerase a universal cancer target? [editorial] J Natl Cancer Inst 1995;87:859-61
2. Battifora H. The telomerase story: No end in sight? [editorial]. Am J Clin Pathol 1997;107:505
3. Lundblad V, Wright WE. Telomeres and Telomerase: A simple picture becomes complex. Cell 1996;87:369-75
4. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Gen Dev 1996;5:249-55
5. Kim NW, Piatyszek MK, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-15
6. Schippen DE. Telomeres and telomerases. Curr Opin Gen Dev 1993;3:759-63
7. Counter CM, Avilion AA, Lefeuvre CE, Stewart NG, Greider CW, Harley CB, Bachetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-29
8. Biessman H, Mason JM. Genetics and molecular biology of telomeres. Adv Gen 1992;30:185-249
9. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW. Telomerase activity in human brain tumors. Lancet 1995;346:1267-68
10. DeMasters BKK, Markham N, Lillehei K, Shroyer KR. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol 1997;107:548-54
11. Langford L, Piatyszek MA, Ruishu X, Schold SC, Wright WE, Shay JW. Telomerase activity: A prognostic indicator in ordinary meningiomas. Hum Pathol 1997;28:416-20
12. Milchgrub S, Yashima K, Saboorian MH, et al. Expression of telomerase RNA during multistage pathogenesis of breast cancer [abstract]. Mod Pathol 1997;10:23
13. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, Gazdar AF. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-17
14. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol 1994;87:47-54
15. Kleihues P, Burger PC, Scheitauer BW. Histological typing of tumors of the central nervous system, 2nd ed. Berlin:Springer Verlag, 1993:5-30
16. Yashima K, Litzky L, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-77
17. Feng J, Funk WD, Wang S-S et al. The RNA component of human telomerase. Science 1995;269:1236-41
18. Mehta C, Patel N. StatXact-turbo user manual. CYTEL Software Corporation, Cambridge MA:1992
19. Burger PC, Vogel FS. Surgical pathology of the nervous system and its coverings, 2nd ed. New York: John Wiley and Sons; 1992: 271-86; 637-46
20. Russel DS, Rubenstein LJ. Pathology of tumours of the nervous system, 5th ed. Baltimore: Williams & Wilkins; 1989:192-219
21. Schiffer D, Chio A, Giordana MT. Histologic prognostic factors in ependymoma. Child's Nerv Syst 1991;7:177-82
22. Rawlings CE, Giangospero F, Burger PC, Bullard DE. Ependymomas: A clinicopathologic study. Surg Neurol 1988;29:271-81
23. Rorke LB. Relationship of morphology of ependymomas in children to prognosis. Prog in Exp Tumor Res 1987;30:170-74
24. Ross GW, Rubenstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989;70:31-36
25. Specht CS, Smith TW, DeGirolami U, Price M. Myxopapillary ependymoma of the filum terminale: A light and electron microscopic study. Cancer 1986;58:310-17
26. Spoto GP, Press GA, Hesselink JR, Solomon M. Intracranial ependymoma and subependymoma. MR manifestations. AJR 1990;154: 837-45
27. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63
28. Schröder R, Ploner C, Ernestus R-I. The growth of ependymomas with varying grades of malignancy measured by the Ki-67 labeling index and mitotic index. Neurosurg Rev 1993;16:145-50
29. Sorrels KS, Craver RD, Correa H. MIB-1 proliferation indices in pediatric ependymomas [abstract]. Am J Clin Path 1997;107:469
30. Prayson RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry [abstract]. J Neuropathol Exp Neurol 1997;56:583
31. Salinen P, Miettinen H, Sallinen S-L, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytes. Am J Pathol 1997;150:1159-64